Retraction Notice to: Circular RNA Cdr1as Upregulates SCAI to Suppress Cisplatin Resistance in Ovarian Cancer via miR-1270 Suppression.

[This retracts the article DOI: 10.1016/j.omtn.2019.07.012.].

Interface regulation of Zr-MOF/Ni2P@nickel foam as high-efficient electrocatalyst for pH-universal hydrogen evolution reaction.

Currently, the development of economical and effective non-noble metal electrocatalysts is vital for advancing hydrogen evolution reaction (HER) and enabling its widespread applications. The customizable pore structure and enormous surface area of metal-organic frameworks (MOFs) have made them to become promising non-noble metal electrocatalysts for HER. However, MOFs have some challenges, including low conductivity and instability, which can result in them having high overpotentials and slow reaction kinetics in electrocatalytic processes. In this work, we present an innovative approach for synthesizing cost-effective and high-efficient Zr-MOF-derived pH-universal electrocatalysts for HER. It entails creating the interfaces of the electrocatalysts with suitable proportions of phosphide nanostructures. Zr-MOF/Ni2P@nickel foam (NF) electrodes with interface regulated by Ni2P nanostructures were successfully developed for high-efficient pH-universal HER electrocatalysts. The presence of Ni2P nanostructures with abundant active sites at the Zr-MOFs@NF interfaces boosted the electronic conductivity and local charge density of the hybrid electrocatalysts. This helped to improve their reaction kinetics and electrocatalytic activity. By optimizing the Ni2P amount, Zr-MOF/Ni2P@NF demonstrated impressive stability and superior HER activities, with a low overpotential of 149 mV (acidic electrolytes) and 143 mV (alkaline electrolytes) at 10 mA cm-2. The proven strategy in this work can be expanded to many types of MOF-based materials for wider practical applications.

Survival outcomes of robotic-assisted laparoscopy versus conventional laparoscopy and laparotomy for endometrial cancer: A systematic review and meta-analysis.

OBJECTIVE: Robotic-assisted laparoscopy (RALS) has gained widespread acceptance in the field of gynecological oncology. However, whether the prognosis of endometrial cancer after RALS is superior to conventional laparoscopy (CLS) and laparotomy (LT) remains inconclusive. Therefore, the aim of this meta-analysis was to compare the long-term survival outcomes of RALS with CLS and LT for endometrial cancer. METHODS: A systematic literature search was conducted on electronic databases (PubMed, Cochrane, EMBASE and Web of Science) until May 24, 2022, followed by a manual search. Based on inclusion and exclusion criteria, publications investigating long-term survival outcomes after RALS vs CLS or LT in endometrial cancer patients were collected. The primary outcomes included overall survival (OS), disease-specific survival (DSS), recurrence-free survival (RFS) and disease-free survival (DFS). Fixed effects models or random effects models were employed to calculate the pooled hazard ratios (HRs) and 95% confidence intervals (CIs) as appropriate. Heterogeneity and publication bias were also assessed. RESULTS: RALS and CLS had no difference in OS (HR = 0.962, 95% CI: 0.922-1.004), RFS (HR = 1.096, 95% CI: 0.947-1.296), and DSS (HR = 1.489, 95% CI: 0.713-3.107) for endometrial cancer; however, RALS was significantly associated with favorable OS (HR = 0.682, 95% CI: 0.576-0.807), RFS (HR = 0.793, 95% CI: 0.653-0.964), and DSS (HR = 0.441, 95% CI: 0.298-0.652) when compared with LT. In the subgroup analysis of effect measures and follow-up length, RALS showed comparable or superior RFS/OS to CLS and LT. In early-stage endometrial cancer patients, RALS had similar OS but worse RFS than CLS. CONCLUSIONS: RALS is safe in the management of endometrial cancer, with long-term oncological outcomes equivalent to CLS and superior to LT.

Zr-MOF/NiS2 hybrids on nickel foam as advanced electrocatalysts for efficient hydrogen evolution.

As a typical transition-metal sulfides (TMS), nickel disulfide (NiS2) has attracted great attention in terms of hydrogen evolution reaction (HER). Howbeit, owing to the poor conductivity, slow reaction kinetics and instability of NiS2, its HER activity is still necessary to be improved. In this work, we designed hybrid structures consisting of the nickel foam (NF) as a self-supporting electrode, NiS2 derived from the sulfuration of NF and Zr-MOF grown on the surface of NiS2@NF (Zr-MOF/NiS2@NF). Due to the synergistic effect between the different constituents, the obtained Zr-MOF/NiS2@NF demonstrates ideal electrochemical hydrogen evolution ability in acidic and alkalescent environment, reaching a standard current density of 10 mA cm-2 at overpotentials of 110 and 72 mV in 0.5 M H2SO4 and 1 M KOH electrolytes, respectively. What is more, it also maintains excellent electrocatalytic durability for 10 h in both electrolytes. This work could provide a useful guidance on effectively combining metal sulfide with MOF for high-performance HER electrocatalysts.

Prussian blue analogue derived cobalt-nickel phosphide/carbon nanotube composite as electrocatalyst for efficient and stable hydrogen evolution reaction in wide-pH environment.

Transition metal phosphides, especially bimetallic phosphides, are promising noble-metal-free electrocatalysts for hydrogen evolution reaction (HER). However, their inferior charge transfer ability constrains further performance improvement. In this work, a facile strategy is reported to fabricate Co2P/Ni2P/carbon nanotube (CNT) composite from a precursor Co-Ni Prussian blue analogue. The combination of Co2P/Ni2P and CNT endows Co2P/Ni2P/CNT with improved electrical conductivity and a richer electrochemically active surface area. As a result, the Co2P/Ni2P/CNT composite exhibits desirable HER activities across a wide pH range, delivering a benchmark current density of 10 mA cm-2 at overpotentials as low as 151 and 202 mV in 0.5 M H2SO4 and 1 M KOH electrolytes, respectively, as well as remarkable electrocatalytic stabilities over 48 h in both electrolytes. This strategy enables the design of high-performance electrocatalysts for efficient and stable hydrogen generation.

Well-designed oxidized Sb/g-C3N4 2D/2D nanosheets heterojunction with enhanced visible-light photocatalytic disinfection activity.

2D/2D heterojunction photocatalysts with excellent photocatalytic activity highlight considerable potential in water disinfection. Here, an oxidized Sb/g-C3N4 2D/2D nanosheets heterojunction (Sb-SbOx/CNS) was constructed based on a facile one-step liquid-phase exfoliation method using concentrated sulfuric acid. By doing so, bulk Sb and g-C3N4 were exfoliated simultaneously and then, intercalated each other. Compared with CNS and Sb-SbOx, the obtained Sb-SbOx/CNS demonstrated better photocatalytic disinfection activity towards Escherichia coli K-12 (E. coli K-12) under visible light irradiation. The 5% oxidized Sb/g-C3N4 2D/2D nanosheets heterojunction (5.0% Sb-SbOx/CNS) exhibited the best photocatalytic performance and admirable cycling stability, which was ascribed to the unique structure where the interfacial charge separation was strengthened by the strong coupling effect between Sb-SbOx and CNS. Meanwhile, the fundamental mechanism of photocatalytic disinfection was also proposed. The photogenerated ROS (reactive oxygen species) violently attacked the E. coli K-12 membrane, creating massive and irreparable holes on the cell membrane. The leakage of cations (K+, Na+, Ca2+ and Mg2+), adenosine triphosphate, total soluble sugar and protein accelerated the destruction of E. coli K-12. Trapping experiments suggested that the photocatalytic disinfection process against E. coli K-12 was dominated by h+ generated on 5.0% Sb-SbOx/CNS. This work offers a new promising way to modify the 2D/2D heterojunction featuring efficient photocatalytic disinfection performance.

The impact of marital status on stage at diagnosis and survival of female patients with breast and gynecologic cancers: A meta-analysis.

The aim of this meta-analysis is to evaluate the effect of marital status on the stage at diagnosis and survival of female patients with breast and gynecologic cancers. A systematic literature search was conducted on electronic databases (PubMed, Cochrane and EMBASE) till December 31, 2020. Publications investigating the association of marital status with stage at diagnosis and/or cancer-specific mortality (CSM) and/or overall survival (OS) in female patients with breast or gynecologic cancers were retrieved. After studies were selected according to inclusion criteria, data extraction, quality assessment and data analysis were performed. 55 articles were eligible for inclusion, consisting of 1,195,773 female cancer patients with breast, vulvar, cervical, endometrial and ovarian cancers. Unmarried female cancer patients had higher odds of being diagnosed at later stage [odds ratio (OR) = 1.28, 95% confidence interval (CI): 1.22-1.36)] and worse survival outcomes in CSM [hazard ratio (HR) = 1.22, 95% CI: 1.16-1.28] and OS (HR = 1.20, 95% CI: 1.14-1.25). This estimate did not vary by level of social support, number of adjustment factors, or between America and Europe. Being married is associated with timely diagnosis and favorable prognosis in most women's cancers. Unmarried female cancer patients have a higher risk of late-stage diagnosis and worse survival outcomes than the married. Greater concern shall be demonstrated towards unmarried female cancer patients. Furthermore, the impact of lacking economic and emotional support on survival outcomes in unmarried female cancer patients deserves particular attention.

miR-16-5p/PDK4-Mediated Metabolic Reprogramming Is Involved in Chemoresistance of Cervical Cancer.

Cervical cancer is one of the most prevalent malignancies in women worldwide. Therefore, investigation about molecular pathogenesis and related therapy targets of cervical cancer is an emergency. The molecular mechanisms responsible for the chemoresistance of cervical cancer were investigated by the use of doxorubicin (Dox)-resistant HeLa/Dox and SiHa/Dox cells. Our data showed that chemoresistant cells exhibited significantly higher glucose consumption, lactate production rate, and ATP levels than that of their parental cells. Among metabolic and glycolytic related genes, the expression of PDK4 was upregulated in Dox-resistant cells. Knockdown of PDK4 can decrease glucose consumption, lactate production rate, and ATP levels and further sensitize resistant cervical cancer cells to Dox treatment. By screening microRNAs (miRNAs), which can regulate expression of PDK4, we found that miR-16-5p was downregulated in chemoresistant cells. Overexpression of miR-16-5p can decrease the expression of PDK4 and sensitize the resistant cells to Dox treatment. Xenograft models confirmed that knockdown of PDK4 can increase chemotherapy efficiency for in vivo tumor growth. Collectively, our data suggested that miR-16-5p/PDK4-mediated metabolic reprogramming is involved in chemoresistance of cervical cancer.

Ca2+ signaling modulation using cancer cell membrane coated chitosan nanoparticles to combat multidrug resistance of cancer.

Off-target drug delivery, together with multidrug resistance (MDR), are two keys obstacles that account for the disappointing outcome in clinical chemotherapy of cancer. To solve these dilemmas, Herein, we constructed cancer cell membrane (CCM) modified silica (CS) nanoparticles (CCM/CS) to co-deliver Ca2+ channel siRNA with doxorubicin (DOX) to construct a platform (CCM/CS/R-D) for the efficient therapy of cervical cancer. It was demonstrated that the optimal CCM/CS/R-D was spherical nanoparticles with size at 122.39 ±â€¯4.69 nm and the surface charge of -27.76 ±â€¯3.12 mV. In addition, the CCM/CS/R-D showed acid responsive drug release while high stability under physiological conditions with negligible hemolysis. The CCM/CS/R-D showed CCM mediated cellular uptake and efficient endosomal escape as well as siRNA transfection potential (comparable to that of PEI 25 K) on MDR cervical cancer cells (HeLa/DOX). Most importantly, the MDR of cancer cells was conquered through modulation of T-type Ca2+ (Cav) channels. It was observed that the Cav channel siRNA could negatively regulate the level of cytosolic Ca2+ concentration which triggered G0/G1 phase cell cycle arrest and elevated intracellular drug retention in HeLa/DOX cells without significantly affect the expression of P-glycolprotein (P-gp). The in vitro and in vivo experiments revealed that CCM/CS/R-D exerted greatly enhanced tumor targetability and therapeutic effect on HeLa/DOX, which was superior than CS/R-D or mono delivery system (CCM/CS/R or CCM/CS/D).

Circular RNA Cdr1as Upregulates SCAI to Suppress Cisplatin Resistance in Ovarian Cancer via miR-1270 Suppression.

The aim of this study is to explore the roles of circular RNA (circRNA) Cdr1as on cisplatin resistance in ovarian cancer and explore the underlying mechanisms. We investigated the expression of circRNAs in five paired cisplatin-sensitive and cisplatin-resistant tissues of ovarian cancer by microarray analysis. The quantitative real-time PCR analysis was to investigate the expression pattern of Cdr1as in cisplatin-resistant ovarian cancer patient tissues and cell lines. Then, the effects of Cdr1as on cisplatin resistance, cell proliferation, and apoptosis were assessed in ovarian cancer cells. In this study, Cdr1as was observed to be downregulated in cisplatin-resistant patient tissues and cell lines. Overexpression of Cdr1as inhibited cell proliferation and promoted the cisplatin-induced cell apoptosis in ovarian cancer cells. Then we demonstrated that repressed Cdr1as promoted the miR-1270 expression, and miR-1270 could bind to the predicted binding site of Cdr1as. Furthermore, we found that miR-1270 displayed its role via modulating the Suppressor of Cancer Cell Invasion (SCAI) expression. Importantly, we demonstrated that Cdr1as was downregulated in serum exosomes from cisplatin-resistant patients. In summary, our study demonstrated that Cdr1as sensitizes ovarian cancer to cisplatin by regulating the miR-1270/SCAI signaling pathway.

Exposure to lethal levels of benzo[a]pyrene or cadmium trigger distinct protein expression patterns in earthworms (Eisenia fetida).

Different pollutants induce distinct toxic responses in earthworms (Eisenia fetida). Here, we used proteomics techniques to compare the responses of E. fetida to exposure to the 10% lethal concentration (14d-LC10) of benzo[a]pyrene (BaP) or cadmium (Cd) in natural red soil (China). BaP exposure markedly induced the expression of oxidation-reduction proteins, whereas Cd exposure mainly induced the expression of proteins involved in transcription- and translation-related processes. Furthermore, calmodulin-binding proteins were differentially expressed upon exposure to different pollutants. The calcium (Ca2+)-binding cytoskeletal element myosin was down-regulated upon BaP treatment, whereas the Ca2+-binding cytoskeletal element tropomyosin-1 was up-regulated upon Cd treatment. Some proteins exhibited opposite responses to the two pollutants. For instance, catalase (CAT) and heat shock protein 70 were up-regulated upon BaP treatment and down-regulated upon Cd treatment. A significant (p<0.05, one-way ANOVA with least-significant difference (LSD) test) increase in the level of reactive oxygen species (ROS) and CAT activity further showed that BaP mainly induces oxidative stress. Real-time PCR analysis showed that mRNA expression often did not correlate well with protein expression in earthworms subjected to Cd or BaP treatment. In addition, the expression of the gene encoding the protein metallothionein, which was not detected in the protein analysis, was induced upon Cd treatment, but slightly reduced upon BaP treatment. Therefore, BaP and Cd have distinct effects on the protein profile of E. Fetida with BaP markedly inducing ROS activity, and Cd mainly triggering genotoxicity. CAPSULE SUMMARY: Distinct patterns of protein expression are induced in earthworms upon exposure to different pollutants; BaP markedly induces high levels of ROS, while Cd resultes in genotoxicity.

On the development of extragonadal and gonadal human germ cells.

Human germ cells originate in an extragonadal location and have to migrate to colonize the gonadal primordia at around seven weeks of gestation (W7, or five weeks post conception). Many germ cells are lost along the way and should enter apoptosis, but some escape and can give rise to extragonadal germ cell tumors. Due to the common somatic origin of gonads and adrenal cortex, we investigated whether ectopic germ cells were present in the human adrenals. Germ cells expressing DDX4 and/or POU5F1 were present in male and female human adrenals in the first and second trimester. However, in contrast to what has been described in mice, where 'adrenal' and 'ovarian' germ cells seem to enter meiosis in synchrony, we were unable to observe meiotic entry in human 'adrenal' germ cells until W22. By contrast, 'ovarian' germ cells at W22 showed a pronounced asynchronous meiotic entry. Interestingly, we observed that immature POU5F1+ germ cells in both first and second trimester ovaries still expressed the neural crest marker TUBB3, reminiscent of their migratory phase. Our findings highlight species-specific differences in early gametogenesis between mice and humans. We report the presence of a population of ectopic germ cells in the human adrenals during development.